Researchers have applied click chemistry, a Nobel Prize-winning technique, for the first time in human cancer patients to selectively deliver chemotherapy directly to tumors. This approach minimizes systemic toxicity and side effects by chemically activating drugs only at the tumor site, demonstrating a novel precision strategy in oncology therapeutics with promising safety profiles.